A Review of Paclitaxel and Novel Formulations Including Those Suitable for Use in Dogs

por Khanna, C., Rosenberg, M., Vail, D. M.
Publicado 2015

Efficacy of Radiation Therapy for the Treatment of Sialocele in Dogs

por Poirier, V.J., Mayer‐Stankeová, S., Buchholz, J., Vail, D.M., Kaser Hotz, B.
Publicado 2017

Phase II Evaluation of VDC‐1101 in Canine Cutaneous T‐Cell Lymphoma

por Morges, M.A., Burton, J.H., Saba, C.F., Vail, D.M., Burgess, K.E., Thamm, D.H.
Publicado 2014

Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma

por Thamm, D.H., Vail, D.M., Post, G.S., Fan, T.M., Phillips, B.S., Axiak‐Bechtel, S., Elmslie, R.S., Klein, M.K., Ruslander, D.A.
Publicado 2017

Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs

por Burton, J.H., Venable, R.O., Vail, D.M., Williams, L.E., Clifford, C.A., Axiak‐Bechtel, S.M., Avery, A.C., Thamm, D.H.
Publicado 2015

c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine

por Weishaar, K.M., Ehrhart, E.J., Avery, A.C., Charles, J.B., Elmslie, R.E., Vail, D.M., London, C.A., Clifford, C.A., Eickhoff, J.C., Thamm, D.H.
Publicado 2017